Can Novavax Win FDA Approval for COVID-19 Vaccine Before Year End? Analyst Weighs In

You can’t always get what you want, but if you try sometimes… You do get what you want?After initially being excluded from the U.S. government’s Operation Warp Speed (OWS) program, Novavax (NVAX) joined the list of companies eligible for federal support.On July 7, the vaccine specialist announced it will receive $1.6 billion from the federal government to support the development of its COVID-19 vaccine candidate, NVX-CoV2373. 5-star B.Riley FBR analyst Mayank Mamtani is impressed by the scale of the award itself, noting: “[T]his funding is the largest granted by OWS to date, correlating with the (1) robustness of preclinical data …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.